Similar Search Results

Assessing consumer gains from a drug price control policy in the United States

Santerre, Rexford E.; Vernon, John A. - In: Southern economic journal 73 (2006) 1, pp. 233-245

Persistent link: https://www.econbiz.de/10003353924

The impact of indirect government controls on US drug prices and R&D

Santerre, Rexford E.; Vernon, John A.; Giaccotto, Carmelo - In: The Cato journal : an interdisciplinary journal of … 26 (2006) 1, pp. 143-158

Persistent link: https://www.econbiz.de/10003317951

An exploratory study of FDA new drug review times, Prescription Drug User Fee Acts, and R&D spending

Vernon, John A.; Golec, Joseph; Lutter, Randall W.; … - In: The quarterly review of economics and finance : journal … 49 (2009) 4, pp. 1260-1274

Persistent link: https://www.econbiz.de/10003903758

Generic utilization rates, real pharmaceutical prices, and research and development expenditures

Cook, Joseph P.; Hunter, Graeme; Vernon, John A. - 2010

"The NBER Bulletin on Aging and Health provides summaries of publications like this. You can sign up to receive the NBER Bulletin on Aging and Health by email. Generic utilization rates have risen substantially since the enactment of The Drug Price Competition and Patent Term Restoration Act...

Persistent link: https://www.econbiz.de/10003936940